Trial Profile
A Study to Evaluate the Treatment Patterns Among Once Monthly Paliperidone Palmitate Treated Patients With Schizophrenia Reaching Stabilized Maintenance Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2016
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 20 Jun 2016 New trial record
- 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research